<DOC>
	<DOCNO>NCT03025828</DOCNO>
	<brief_summary>The purpose study evaluate effect adrenocorticotropic hormone ( ACTH , Acthar ) loss protein urine ( proteinuria ) patient membranous nephropathy . Acthar hormone stimulate steroid production small gland kidney . It direct protective effect kidney currently approve FDA treat kidney disorder associate protein urine , mechanisms action entirely understood study present trial .</brief_summary>
	<brief_title>Adrenocorticotropic Hormone Membranous Nephropathy</brief_title>
	<detailed_description>Patients membranous nephropathy nephrotic syndrome treat ACTH 6 month . Proteinuria remission 12 month primary endpoint . Different biomarkers include anti-PLA2R autoantibody , circulate regulatory T cell , autoreactive memory B cell serially measure identify predictor response therapy .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , Membranous</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<mesh_term>Melanocyte-Stimulating Hormones</mesh_term>
	<mesh_term>beta-Endorphin</mesh_term>
	<criteria>Age 18 70 year Free immunosuppression least 3 month Capability understand purpose study Written inform consent epidermal growth factor receptor ( eGFR ) &lt; 30ml/min/1.73m2 Kidney Transplant Secondary MN ( define basis clinical criterion ) Type 1 Type 2 diabetes mellitus ( prior diagnosis gestational diabetes mellitus exclusion ) History previous use Acthar treatment nephrotic syndrome Prior sensitivity Acthar porcine protein product Contraindication Acthar per Prescribing Information Planned treatment live live attenuate vaccine enrol study More three previous treatment regiment Participation clinical trial previous 12 month History cancer , except carcinoma situ treat basal squamous cell carcinoma Pregnancy Lactation Current substance abuse Any clinically relevant condition might affect study participation and/or study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Membranous nephropathy</keyword>
	<keyword>adrenocorticotropic hormone</keyword>
	<keyword>ACTH</keyword>
	<keyword>proteinuria</keyword>
	<keyword>glomerulonephritis</keyword>
</DOC>